FDA approval of peramivir makes IV flu drug available

December 23, 2014 1:03 AM

4 0

FDA approval of peramivir makes IV flu drug available

The US Food and Drug Administration (FDA) today announced the approval of the antiviral drug peramivir (Rapivab), making an intravenous (IV) medication available for adult influenza patients who have trouble taking an oral or inhaled antiviral.

Peramivir, made by BioCryst Pharmaceuticals Inc., is a neuraminidase inhibitor (NI), like the licensed drugs oseltamivir (Tamiflu), taken orally, and zanamivir (Relenza), which is inhaled. It is intended to be given in a single dose.

Read more

To category page

Loading...